CXCR4 and Miyoshi myopathy: In experimental murine models of MM, it has been shown that CXCR4 inhibition by AMD3100 disrupts the interaction of MM cells with BM and enhances MM mobilization to circulation and sensitivity to therapeutic agents [12].